InvestorsHub Logo
Followers 47
Posts 5355
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Saturday, 10/20/2018 12:29:16 PM

Saturday, October 20, 2018 12:29:16 PM

Post# of 471830
Dr. M wanted to start all three trials close together in 2017 for a reason. The reason IMO was to overwhelm the world with irrefutable precision fact based data. That didnt happen obviously do to any one of a myriad of reasons. Now a year later we have three trials cleared for take off. These are genomic precision medicine trials ALL using biomarkers for stratification.

Ladies and gentlemen we are ready to start the race! The race to getting A 2-73 to market. A race to approval for not one but possibly all three indications through new trial protocols. Say what you want about Dr M but IMO the glass is not half full anymore, it just became 3/4 full and going forward there is no way you can misinterpret this glass as half empty. Just a matter of time now for the market to organise their thoughts and get in. The longer they wait the higher we may go! They knew they had time. but with new protocols comes new efficiencies and with new efficiency comes faster paths for approval.

Tempered expectations with respect of the pps until an early readout of one of the trials happens or partnership is announced! Trust the PLAN!

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News